Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of Nivolumab for Early Stage Hodgkin Lymphoma in Patients with Good Prognosis
ItalyStudy on Cemiplimab for Patients with High-Risk Stage III/IV Cutaneous Squamous Cell Carcinoma
ItalyStudy on the Effect of Lutropin Alfa to Improve Ovarian Reserve in Patients Undergoing IVF/ICSI Due to Tubal, Male Factor, or Unexplained Infertility
ItalyStudy on Trabectedin and Radiotherapy for Patients with Soft Tissue Sarcoma
ItalyStudy of Ziftomenib with Chemotherapy for Children with Relapsed or Refractory Acute Leukemia
ItalyStudy on Elacestrant and Everolimus for Patients with Advanced ER+/HER2- Breast Cancer Resistant to Endocrine Therapy and CDK4/6 Inhibitors
ItalyStudy of Satralizumab for Children with Neuromyelitis Optica Spectrum Disorder (NMOSD)
ItalyStudy on Cannabis Extract for Improving Quality of Life in Patients with Alzheimer's, Parkinson's, or ALS Using Dronabinol and Cannabidiol
ItalyStudy of Sarilumab for Children and Adolescents with Systemic Juvenile Idiopathic Arthritis (sJIA)
ItalyStudy on Prasugrel and Acetylsalicylic Acid for Patients with ST-Elevated Myocardial Infarction Undergoing Different Revascularization Techniques
ItalyStudy on APL-101 for Treating Advanced Solid Tumors and Non-Small Cell Lung Cancer with MET Changes in Patients
ItalyStudy on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
